Meihua International Medical Technologies Co., Ltd. (MHUA) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Medium Risk
Moderate dilution risk
Last updated: April 29, 2026

Risk Assessment Details

Potential Dilution: 3953.28% of current shares
Recent Dilution: 0% (2 years)
Historical Dilution Factor: minimal recent dilution
Outstanding Shares
700K
Potential Supply
28M
Additional shares possible
Splits
None
Past 2 years

Summary

MHUA currently has 698K outstanding shares. with significant dilution risk as 27.6M authorized shares could dilute existing holders by 3953.3%. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Apr 29, 2026

20-F filing | 0.7M shares outstanding

700K 28M
Apr 25, 2025

20-F filing | 31.9M shares outstanding

32M 28M
Apr 24, 2024

20-F filing | 23.9M shares outstanding

24M 28M
Feb 06, 2024

F-1 filing: This F-1 filing relates to the potential resale of 1,205,255 ordinary shares issuable upon the exercise of warrants by selling shareholders; the warrants have an exercise price of $2.9869 per share.

24M 28M
Aug 24, 2023

F-3 filing: Meihua International Medical Technologies Co., Ltd. may offer and sell up to $100,000,000 of its ordinary shares, preferred shares, debt securities, warrants, rights, and units, or any combination thereof.

23M 26M
Apr 14, 2023

20-F filing | 23.4M shares outstanding

23M 0
Jul 29, 2022

20-F filing | 23.9M shares outstanding

24M 0
Aug 10, 2021

F-1 filing: Initial public offering to create a public market for shares, retain talented employees with equity incentives, and obtain additional capital for research and development, selling and marketing, equipment acquisition, general corporate purposes and working capital.

20M 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime